Versican Plus DHP inj. susp. (lyoph. + solv.) s.c. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

versican plus dhp inj. susp. (lyoph. + solv.) s.c. vial

zoetis belgium sa-nv - canine adenovirus 2 (live, attenuated) ; canine parvovirus (live, attenuated) ; canine distemper virus (live, attenuated) - lyophilisate and solvent for suspension for injection - canine distemper virus (cdv); canine adenovirus type 2; canine parvovirus type 2b - canine distemper virus + canine adenovirus + canine parvovirus + canine parainfluenza virus - dog

Vanguard C3 Injectable Live Vaccine for Dogs Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vanguard c3 injectable live vaccine for dogs

zoetis australia pty ltd - canine distemper virus, strain n-cdv; canine adenovirus type 2, strain manhattan; canine parvovirus, strain nl-35-d; gentamicin - misc. vaccines or anti sera - canine distemper virus, strain n-cdv vaccine-viral active 0.0 p; canine adenovirus type 2, strain manhattan vaccine-viral active 0.0 p; canine parvovirus, strain nl-35-d vaccine-viral active 0.0 p; gentamicin antibiotic other 30.0 ug/ml - immunotherapy

VANGUARD 5 New Zealand - English - Ministry for Primary Industries

vanguard 5

zoetis new zealand limited - canine parvovirus (attenuated); canine distemper virus (attenuated); canine parainfluenza virus (attenuated); canine adenovirus type 2 (attenuated) - canine parvovirus (attenuated) 0 vaccine; canine distemper virus (attenuated) 0 vaccine; canine parainfluenza virus (attenuated) 0 vaccine; canine adenovirus type 2 (attenuated) 0 vaccine - vaccine

Quantum Dog DAPPvL+Cv Formulation: Each dose of DAPPvLa vaccine contains: Modified Live Virus Canine Distemper Virus (CDV) (Distemperoid Strain) >10^3.7 TCID 50/dose Modified Live Virus Canine Adenovirus Type 2 (CAV-2) (Ditchfield Strain) >10^4.8 TCID 50/dose Modified Live Virus Canine Parainfluenza (CPI) (CPI-PR Strain)- >10^4.3 TCID 50/dose Modified Live Virus Canine Parvovirus (CPV) (SAH-CPV-2b Strain) >10^5.1 TCID 50/dose Bacterin Leptospira canicola (LC-NY strain)>80 hamster PD80 Bacterin Leptospira icterohaemorrhagiae (LI-11403 J strain)>80 hamster PD80 Each dose of Canine 1-Cv vaccine contains: Killed Virus Feline Enteric Coronavirus (FECV) (WSU 79-1683(3) strain) >1 RP/dose TCID-Test Culture Infectious Dose FAID- Flouroscent Antibody Infect Due PD-Protective Dose RP-Relative Potency Suspension for Injection (IM/SC) Philippines - English - FDA (Food And Drug Administration)

quantum dog dappvl+cv formulation: each dose of dappvla vaccine contains: modified live virus canine distemper virus (cdv) (distemperoid strain) >10^3.7 tcid 50/dose modified live virus canine adenovirus type 2 (cav-2) (ditchfield strain) >10^4.8 tcid 50/dose modified live virus canine parainfluenza (cpi) (cpi-pr strain)- >10^4.3 tcid 50/dose modified live virus canine parvovirus (cpv) (sah-cpv-2b strain) >10^5.1 tcid 50/dose bacterin leptospira canicola (lc-ny strain)>80 hamster pd80 bacterin leptospira icterohaemorrhagiae (li-11403 j strain)>80 hamster pd80 each dose of canine 1-cv vaccine contains: killed virus feline enteric coronavirus (fecv) (wsu 79-1683(3) strain) >1 rp/dose tcid-test culture infectious dose faid- flouroscent antibody infect due pd-protective dose rp-relative potency suspension for injection (im/sc)

msd animal health (phils), inc.; distributor: msd animal health (phils), inc. - modified live canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parainfluenza virus (cpi) , canine parvovirus (cpv) , inactivated leptospira interrogans ser. canicola , leptospira interrogans ser. icterohaemorrhagiae , coronavirus vaccine (vet.) - suspension for injection (im/sc) - formulation: each dose of dappvla vaccine contains: modified live virus canine distemper virus (cdv) (distemperoid strain) >10^3.7 tcid 50/dose modified live virus canine adenovirus type 2 (cav-2) (ditchfield strain) >10^4.8 tcid 50/dose modified live virus canine parainfluenza (cpi) (cpi-pr strain)- >10^4.3 tcid 50/dose modified live virus canine parvovirus (cpv) (sah-cpv-2b strain) >10^5.1 tcid 50/dose bacterin leptospira canicola (lc-ny strain)>80 hamster pd80 bacterin leptospira icterohaemorrhagiae (li-11403 j strain)>80 hamster pd80 each dose of canine 1-cv vaccine contains: killed virus feline enteric coronavirus (fecv) (wsu 79-1683(3) strain) >1 rp/dose tcid-test culture infectious dose faid- flouroscent antibody infect due pd-protective dose rp-relative potency

EURICAN DHPPI LYOPHILISATE FOR SUSPENSION FOR INJECTION Ireland - English - HPRA (Health Products Regulatory Authority)

eurican dhppi lyophilisate for suspension for injection

merial animal health limited - attenuated canine distemper virus, strain ba5, attenuated canine adenovirus type 2, strain dk13, attenuated canine parvovirus, strain cag2, attenuated canine parainfluenza virus type 2, strain cgf 2004/75 - lyophilisate for suspension - unknown - canine distemper virus vaccine + canine adenovirus vaccine + canine parvovirus vaccine + canine para - canine - immunological - live vaccine

EURICAN DAP LYOPHILISATE AND SOLVENT FOR SUSPENSION FOR INJECTION Ireland - English - HPRA (Health Products Regulatory Authority)

eurican dap lyophilisate and solvent for suspension for injection

merial animal health limited - attenuated canine distemper virus, strain ba5, attenuated canine adenovirus type 2, strain dk13, attenuated canine parvovirus, strain cgf - lyophilisate and solvent for suspension for injection - unknown - canine distemper virus vaccine + canine adenovirus vaccine + canine parvovirus vaccine - canine - immunological - live vaccine

NOBIVAC DHP New Zealand - English - Ministry for Primary Industries

nobivac dhp

schering-plough animal health limited - canine distemper virus (attenuated); canine parvovirus (attenuated); canine adenovirus type 2 (attenuated) - canine distemper virus (attenuated) 0 vaccine; canine parvovirus (attenuated) 0 vaccine; canine adenovirus type 2 (attenuated) 0 vaccine - vaccine

Canigen DHPPi/L inj. susp. (lyoph. + susp.) s.c. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

canigen dhppi/l inj. susp. (lyoph. + susp.) s.c. vial

virbac s.a. - canine distemper virus (cdv) (lyophilisate); canine adenovirus type 2 (lyophilisate); canine parvovirus (lyophilisate); canine parainfluenza virus (lyophilisate); leptospira interrogans serogroup canicola (inactivated) (suspension); leptospira interrogans serogroup icterohaemorrhagiae (inactivated) (suspension) - lyophilisate and suspension for suspension for injection - canine adenovirus type 2; canine parainfluenza virus; canine distemper virus (cdv); canine parvovirus; leptospira interrogans canicola; leptospira interrogans icterohaemorrhagiae - live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira - dog

Recombitek C6 Each 1.0 mL dose of vaccine contains the following through expiration: Active Ingredients: Canine Distemper, Canarypox Vector .............................................. ≥106.4 TCID50 Canine Adenovirus Type 2 ............................................................. ≥104.3 TCID50 Canine Parainfluenza .................................................................... ≥103.9 TCID50 Canine Parvovirus ........................................................................ ≥103.3 FAID50 Leptospira canicola ....................................................... ≥40 nephelometric units Leptospira icterohaemorrhagiae ...................................... ≥30 nephelometric units *TCID-Tissue Culture Infective Dose **FAID. Fluorescent Antibody Infective Dose ***NTU- Nephelometric Units Lyophilized Powder for Injection (IM/SC) Philippines - English - FDA (Food And Drug Administration)

recombitek c6 each 1.0 ml dose of vaccine contains the following through expiration: active ingredients: canine distemper, canarypox vector .............................................. ≥106.4 tcid50 canine adenovirus type 2 ............................................................. ≥104.3 tcid50 canine parainfluenza .................................................................... ≥103.9 tcid50 canine parvovirus ........................................................................ ≥103.3 faid50 leptospira canicola ....................................................... ≥40 nephelometric units leptospira icterohaemorrhagiae ...................................... ≥30 nephelometric units *tcid-tissue culture infective dose **faid. fluorescent antibody infective dose ***ntu- nephelometric units lyophilized powder for injection (im/sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - modified live recombinant canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) vaccine , inactivated leptospira interrogans ser. canicola , leptospira interrogans ser. icterohaemorrhagiae vaccine (vet.) - lyophilized powder for injection (im/sc) - each 1.0 ml dose of vaccine contains the following through expiration: active ingredients: canine distemper, canarypox vector .............................................. ≥106.4 tcid50 canine adenovirus type 2 ............................................................. ≥104.3 tcid50 canine parainfluenza .................................................................... ≥103.9 tcid50 canine parvovirus ........................................................................ ≥103.3 faid50 leptospira canicola ....................................................... ≥40 nephelometric units leptospira icterohaemorrhagiae ...................................... ≥30 nephelometric units *tcid-tissue culture infective dose **faid. fluorescent antibody infective dose ***ntu- nephelometric units

Recombitek C6/CV 1 dose of 1 ml vaccine contains: Lyophilized: Canine Distemper, Canarypox Vector, at least . . . . . . . . . . . . . . . . . . . . . . . 106.4 TCID50 Canine Adenovirus Type 2, Toronto A/26/61 strain, at least. . . . . . . . . . . . 104.3 TCID50 Canine Parainfluenza virus, D-008 strain, at least . . . . . . . . . . . . . . . . . . . 103.9 TCID50 Canine Coronavirus, K-378/51 strain, at least . . . . . . . . . . . . . . . . . . . . . . . 103.6 TCID50 Canine Parvovirus, 780916 strain, at least . . . . . . . . . . . . . . . . . . . . . . . . . . 103.3 FAID50 Liquid: Leptospira canicola, strain 1503, at least . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 NU Leptospira icterohaemorrhagiae, strain 1518, at least. . . . . . . . . . . . . . . . . . 30 NU Lyophilized Powder for Injection (IM/SC) Philippines - English - FDA (Food And Drug Administration)

recombitek c6/cv 1 dose of 1 ml vaccine contains: lyophilized: canine distemper, canarypox vector, at least . . . . . . . . . . . . . . . . . . . . . . . 106.4 tcid50 canine adenovirus type 2, toronto a/26/61 strain, at least. . . . . . . . . . . . 104.3 tcid50 canine parainfluenza virus, d-008 strain, at least . . . . . . . . . . . . . . . . . . . 103.9 tcid50 canine coronavirus, k-378/51 strain, at least . . . . . . . . . . . . . . . . . . . . . . . 103.6 tcid50 canine parvovirus, 780916 strain, at least . . . . . . . . . . . . . . . . . . . . . . . . . . 103.3 faid50 liquid: leptospira canicola, strain 1503, at least . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 nu leptospira icterohaemorrhagiae, strain 1518, at least. . . . . . . . . . . . . . . . . . 30 nu lyophilized powder for injection (im/sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - modified live recombinant canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) , canine coronavirus (ccv) , inactivated leptospira interrogans ser. canicola , leptospira interrogans ser. icterohaemorrhagiae vaccine (vet.) - lyophilized powder for injection (im/sc) - 1 dose of 1 ml vaccine contains: lyophilized: canine distemper, canarypox vector, at least . . . . . . . . . . . . . . . . . . . . . . . 106.4 tcid50 canine adenovirus type 2, toronto a/26/61 strain, at least. . . . . . . . . . . . 104.3 tcid50 canine parainfluenza virus, d-008 strain, at least . . . . . . . . . . . . . . . . . . . 103.9 tcid50 canine coronavirus, k-378/51 strain, at least . . . . . . . . . . . . . . . . . . . . . . . 103.6 tcid50 canine parvovirus, 780916 strain, at least . . . . . . . . . . . . . . . . . . . . . . . . . . 103.3 faid50 liquid: leptospira canicola, strain 1503, at least . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 nu leptospira icterohaemorrhagiae, strain 1518, at least. . . . . . . . . . . . . . . . . . 30 nu